Literature DB >> 7853369

Neurofibromatosis type 1 in Israel: survey of young adults.

B Z Garty1, A Laor, Y L Danon.   

Abstract

Neurofibromatosis type 1 (NF1) (von Recklinghausen's disease) is one of the most common human autosomal dominant disorders. In a survey of 374440 17 year old Jewish recruits for military service, 390 cases of NF1 were discovered, with a prevalence of 1.04/1000 (0.94/1000 for males and 1.19/1000 for females), or two to five times the reported prevalence of this disease. NF1 was more common in youngsters whose parents were of North African and Asian origin (1.81/1000 and 0.95/1000, respectively) and less common in those of European and North American origin (0.64/1000). All these differences were statistically significant and may be partially explained by the more advanced parental age of the NF group (as suggested by the larger number of children in the North African and Asian families) or by founder effect or both. The height and weight of the NF1 subjects was significantly lower than those of the controls. The intelligence score of persons with NF1 was similar to that of the control group when corrected for gender and ethnic origin. No significant increase in epilepsy or mental illnesses was found. This study provides evidence of the high overall prevalence of NF1 among Jews in Israel, with significantly increased prevalence in certain ethnic groups.

Entities:  

Mesh:

Year:  1994        PMID: 7853369      PMCID: PMC1016658          DOI: 10.1136/jmg.31.11.853

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  25 in total

1.  On the mutation rate of neurofibromatosis.

Authors:  A S Sergeyev
Journal:  Humangenetik       Date:  1975-06-19

2.  Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

Authors:  J C Carey; J M Laub; B D Hall
Journal:  Birth Defects Orig Artic Ser       Date:  1979

3.  On the natural history of von Recklinghausen neurofibromatosis.

Authors:  S A Sørensen; J J Mulvihill; A Nielsen
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

5.  Neurofibromatosis in childhood.

Authors:  N L Fienman; W C Yakovac
Journal:  J Pediatr       Date:  1970-03       Impact factor: 4.406

6.  Neurofibromatosis type 1 (Recklinghausen's disease). Neurologic and cognitive assessment with sibling controls.

Authors:  R Eldridge; M B Denckla; E Bien; S Myers; M I Kaiser-Kupfer; A Pikus; S L Schlesinger; D M Parry; J M Dambrosia; M A Zasloff
Journal:  Am J Dis Child       Date:  1989-07

7.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

8.  The genetic aspects of neurofibromatosis.

Authors:  J C Carey; B J Baty; J P Johnson; T Morrison; M Skolnick; J Kivlin
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

9.  Neurofibromatosis. A review of the clinical problem.

Authors:  A E Rubenstein
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

10.  Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.

Authors:  D E Goldgar; P Green; D M Parry; J J Mulvihill
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

View more
  6 in total

Review 1.  Psychological aspects of von Recklinghausen neurofibromatosis (NF1)

Authors:  S E Mouridsen; S A Sørensen
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

2.  Segmental neurofibromatosis presenting with congenital excessive skin folds.

Authors:  Alexander M Helfand; Ariella Nouriel; Jonah Zisquit; Aviv Barzilai; Shoshana Greenberger
Journal:  Dermatol Pract Concept       Date:  2015-04-30

3.  Differential analysis of mutations in the Jewish population and their implications for diseases.

Authors:  Yaron Einhorn; Daphna Weissglas-Volkov; Shai Carmi; Harry Ostrer; Eitan Friedman; Noam Shomron
Journal:  Genet Res (Camb)       Date:  2017-05-15       Impact factor: 1.588

4.  Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.

Authors:  Diogo Lisbôa Basto; Gustavo de Souza Vieira; Raquel M Andrade-Losso; Paula Nascimento Almeida; Vincent M Riccardi; Rafaela Elvira Rozza-de-Menezes; Karin Soares Cunha
Journal:  Orphanet J Rare Dis       Date:  2022-09-05       Impact factor: 4.303

5.  Development of algorithms to identify individuals with Neurofibromatosis type 1 within administrative data and electronic medical records in Ontario, Canada.

Authors:  Carolina Barnett; Elisa Candido; Branson Chen; Priscila Pequeno; Patricia C Parkin; Karen Tu
Journal:  Orphanet J Rare Dis       Date:  2022-08-26       Impact factor: 4.303

6.  Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review.

Authors:  Ike Iheanacho; Hyun Kyoo Yoo; Xiaoqin Yang; Sophie Dodman; Rachel Hughes; Suvina Amin
Journal:  Neurol Sci       Date:  2021-06-18       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.